OH MPJE cheat sheet

Ohio licenses pharmacists, pharmacy interns, and pharmacy technicians through the State Board of Pharmacy; a license is required before performing any function restricted to that credential.

Pharmacist licensure requires graduation from an ACPE-accredited program, passage of NAPLEX and MPJE, and a specified number of internship hours; Ohio uses a score-reporting and application process through the Board.

Pharmacy technician certification in Ohio requires Board registration; certified technicians hold a recognized certification (for example PTCB or ExCPT) and registration must be renewed on the Board's cycle.

A terminal distributor of dangerous drugs (TDDD) license is required for each location that possesses, dispenses, or administers dangerous drugs; the license is site-specific and not transferable.

Licenses and registrations must be renewed before expiration; practicing on an expired license is a violation subject to discipline, and reinstatement may require fees plus continuing education.

Continuing education for Ohio pharmacists totals 40 contact hours per two-year renewal cycle, including at least 2 hours on Ohio pharmacy law and specified hours in medication/patient safety topics.

Pharmacy interns must be enrolled in an accredited program and registered with the Board; interns may perform pharmacist functions only under direct pharmacist supervision.

Change of address, name, or employment must be reported to the Board within the timeframe set by rule; failure to report is an independent violation.

Pharmacists may administer immunizations to patients of appropriate age under Ohio law after completing Board-recognized training; documentation and reporting to the statewide immunization registry apply.

Pharmacist prescribing authority in Ohio is limited to defined categories such as certain self-limiting conditions and contraceptives under collaborative practice or statewide protocols; it is not general prescriptive authority.

Collaborative practice agreements must be in writing, define the scope of the pharmacist's authority, and be maintained on file; the collaborating physician retains oversight responsibilities.

A pharmacist may refuse to fill a prescription based on professional judgment (for example, suspected forgery or therapeutic concern) but must document the reason and notify the prescriber when appropriate.

The pharmacist-in-charge is responsible for compliance with drug storage, recordkeeping, and personnel supervision; only a licensed pharmacist may serve as PIC.

Drugs may be dispensed only pursuant to a valid prescription or as authorized by law; dispensing without a prescription order is permitted only for exempted categories such as certain OTC or sample situations defined by rule.

Pharmacists must provide patient counseling (or offer it) on new prescriptions and when the pharmacist judges it necessary; counseling may be declined by the patient, and the refusal must be documented.

Pharmacy interns and technicians may perform tasks delegated by a pharmacist, but the pharmacist retains responsibility for final verification of the dispensed product.

A valid prescription must include the patient's name, drug name, strength, dosage form, quantity, directions, prescriber's name and signature, and date; missing elements require prescriber verification before dispensing.

Ohio requires prescription records to be retained for at least three years from the date of dispensing (or the date of the last refill), and records must be readily retrievable for inspection.

Prescriptions for controlled substances must be verified against DEA requirements; Schedule II prescriptions cannot be refilled, and partial fills are allowed only in defined circumstances.

Labels must include the pharmacy name and address, prescription number, date, patient name, prescriber name, directions, drug name and strength, quantity, and expiration or beyond-use date as applicable.

Substitution of a generic equivalent is permitted unless the prescriber indicates 'dispense as written' or the patient refuses; the substitution must be documented on the prescription record.

Refills must be authorized by the prescriber and must not exceed the number stated; a prescription with no refills authorized cannot be refilled without new authorization.

Prescriptions transmitted electronically must meet EPCS requirements for controlled substances; oral prescriptions for Schedule II are permitted only in emergency situations with written follow-up within 7 days.

Dispensing errors or suspected errors must be documented and reviewed under the pharmacy's quality assurance program, with corrective action recorded.

DEA registration is required for each location that handles controlled substances; registration is separate from the state TDDD license and both must be current.

Schedule II prescriptions must be written, electronically prescribed per EPCS rules, or oral in a bona fide emergency with a written prescription delivered within 7 days.

Schedule II drugs cannot be refilled; Schedule III–V drugs may be refilled up to five times within six months of the issue date unless the prescriber specifies otherwise.

A DEA Form 222 (or CSOS electronic equivalent) is required to order Schedule I or II substances; the form must be completed accurately and retained per DEA recordkeeping rules.

Controlled substance records, including invoices and dispensing records, must be kept for at least two years and be available for inspection by DEA and state authorities.

Theft or significant loss of controlled substances must be reported to the DEA field office and to the state Board in writing within one business day of discovery.

Schedule V substances may be sold without a prescription only where state law permits and only in the quantities and under the conditions specified; Ohio restricts such sales.

A registrant must maintain a biennial inventory of controlled substances and keep it with other required records.

Records required by Ohio law, including prescription files, purchase invoices, and inventories, must be maintained for the period set by statute and be retrievable within a reasonable time.

A biennial controlled substance inventory must be taken every two years, dated, signed, and include the quantity and strength of each substance on hand.

Drug recalls must be handled by identifying affected stock, quarantining it, and documenting the action taken; recall records should be retained.

Expired or unusable drugs must be removed from active stock and disposed of according to DEA and environmental rules; controlled substance disposal requires DEA-compliant methods.

Inventory records should reconcile purchases, dispensing, and on-hand quantities; unexplained discrepancies require investigation and, where applicable, reporting.

Records may be maintained electronically if the system is reliable, secure, and capable of producing printed copies on request; backup procedures must be in place.

Personnel records, including licensure verification and training documentation, must be maintained and available for Board inspection.

Quality assurance programs must document medication error review, trend analysis, and corrective actions taken to prevent recurrence.

Counseling must be offered for each new prescription and for any prescription when the pharmacist determines it is necessary; the offer and any refusal must be documented.

Counseling content should cover drug name and purpose, directions, common side effects, interactions, storage, and what to do if a dose is missed.

Medication error reporting should follow an established internal process; serious errors may require reporting to external bodies per Board rule.

Quality assurance programs must include a process for identifying, documenting, and analyzing medication errors and near misses, with feedback to staff.

High-alert medications (for example insulin, anticoagulants, and opioids) require additional verification steps such as independent double checks.

Patient counseling must be provided in a manner the patient can understand; interpreters or translated materials should be used when a language barrier exists.

Medication therapy management and comprehensive medication reviews are pharmacist services that require documentation of the assessment and recommendations.

Use of automated dispensing systems requires policies for accuracy checks, override documentation, and periodic audits.

A pharmacy must have a designated pharmacist-in-charge responsible for overall compliance; the PIC must be licensed in Ohio and physically present as required by rule.

The facility must provide adequate space for compounding, dispensing, and record storage, and must be secure against unauthorized access.

Refrigerators and temperature-controlled storage areas must be monitored, with temperature logs maintained to document proper storage conditions.

Personnel must be trained on their duties and on applicable laws; training records must be maintained and updated as required.

Pharmacy technicians must work under the supervision of a licensed pharmacist; the ratio and scope of technician duties are set by Board rule.

The pharmacy must have written policies and procedures covering dispensing, recordkeeping, security, and handling of controlled substances.

Security measures must protect against theft and diversion; access to controlled substance storage should be limited and monitored.

A pharmacy closing or changing ownership must notify the Board and transfer or dispose of records and drugs according to rule.

Federal law sets minimum standards (for example the Controlled Substances Act and FDA rules); Ohio law may impose stricter requirements, and the stricter standard controls.

The Poison Prevention Packaging Act requires child-resistant packaging for most oral prescription drugs unless the prescriber or patient requests otherwise.

The Combat Methamphetamine Epidemic Act imposes recordkeeping, identification, and sales-limit requirements on ephedrine and pseudoephedrine products.

HIPAA privacy rules govern the use and disclosure of protected health information; pharmacies must have safeguards and provide a notice of privacy practices.

DEA registration must be renewed every three years, and state licensure must be maintained continuously; a lapse in either prohibits handling controlled substances.

Inspections by the Board or DEA may occur during business hours; the pharmacy must produce records and cooperate with inspectors.

Violations can result in license discipline, civil penalties, or criminal prosecution; self-reporting and corrective action may mitigate penalties.

Advertising and promotional materials must not be false or misleading, and prescription drug advertising must comply with applicable federal and state rules.